Torthaí cuardaigh - Hilde Decraemer

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

    Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy de réir Man‐Fung Yuen, Erwin Sablon, Chee Kin Hui, He-Jun Yuan, Hilde Decraemer, Ching‐Lung Lai

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay

    Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay de réir Anna S. Lok, Fabien Zoulim, Stephen Locarnini, Alessandra Mangia, Grazia Anna Niro, Hilde Decraemer, Geert Maertens, Frank Hulstaert, K De Vreese, Erwin Sablon

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: